Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02520141
What this trial is testing

Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery

Who this might be right for
CholangiocarcinomaLiver and Intrahepatic Bile Duct CarcinomaStage III Gallbladder Cancer AJCC v7+9 more
M.D. Anderson Cancer Center 61
Early research (Phase 1)Looking for participantsNCT06065371
What this trial is testing

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Who this might be right for
Gastrointestinal Cancer
Henry Ford Health System 20
Early research (Phase 1)Looking for participantsNCT07614061
What this trial is testing

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinoma, IntrahepaticCholangiocarcinoma, Extrahepatic+2 more
Shanghai Zhongshan Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06048133
What this trial is testing

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

Who this might be right for
Biliary Tract CarcinomaCholangiocarcinomaBile Duct Cancer
Nataliya Uboha 33
Testing effectiveness (Phase 2)Looking for participantsNCT06938321
What this trial is testing

AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Akeso 135
Testing effectiveness (Phase 2)UnknownNCT04907864
What this trial is testing

Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE)

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+4 more
Kil Yeon Lee 112
Testing effectiveness (Phase 2)Study completedNCT05253053
What this trial is testing

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more
TransThera Sciences (Nanjing), Inc. 84
Early research (Phase 1)Ended earlyNCT05194072
What this trial is testing

Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms+8 more
Seagen, a wholly owned subsidiary of Pfizer 250
Early research (Phase 1)Looking for participantsNCT07763301
What this trial is testing

YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies

Who this might be right for
Liver CancerPancreatic CancerBiliary Tract Cancer (BTC)
West China Hospital 9
Early research (Phase 1)Looking for participantsNCT06084481
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

Who this might be right for
Hepatocellular CarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancers+5 more
AbbVie 325
Testing effectiveness (Phase 2)Looking for participantsNCT07398339
What this trial is testing

Cosiporfin Sodium for Injection Photodynamic Therapy

Who this might be right for
Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd 30
Early research (Phase 1)Study completedNCT02451553
What this trial is testing

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more
University of Washington 41
Early research (Phase 1)Study completedNCT03082053
What this trial is testing

Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

Who this might be right for
Advanced or Metastatic Biliary Tract CancerAdvanced or Metastatic Solid Tumors
ASLAN Pharmaceuticals 24
Early research (Phase 1)Active Not RecruitingNCT06360354
What this trial is testing

A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Who this might be right for
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Amgen 120
Testing effectiveness (Phase 2)UnknownNCT02632019
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract

Who this might be right for
Advanced Biliary Tract Malignant Tumor
Second Military Medical University 40
Testing effectiveness (Phase 2)Study completedNCT00380588
What this trial is testing

Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Eli Lilly and Company 84
Early research (Phase 1)Looking for participantsNCT07458347
What this trial is testing

Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Who this might be right for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC)KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)KRAS-mutant Colorectal Cancer (CRC)+1 more
Kestrel Therapeutics, Inc. 145
Testing effectiveness (Phase 2)Study completedNCT01216345
What this trial is testing

Cetuximab + Gemox in Biliary Tract Cancer

Who this might be right for
UnresectableLocally AdvancedMetastatic
Association of Research on the Biology of Liver Tumors 30
Testing effectiveness (Phase 2)Study completedNCT02425137
What this trial is testing

S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer(BTC)
TTY Biopharm 51
Early research (Phase 1)Study completedNCT00003411
What this trial is testing

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
University of Pittsburgh
Next Page